Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-10-11
- Last Posted Date
- 2019-12-18
- Lead Sponsor
- OPKO IP Holdings II, Inc.
- Target Recruit Count
- 216
- Registration Number
- NCT01704079
- Locations
- 🇺🇸
OPKO Renal, Bannockburn, Illinois, United States
Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-07-26
- Last Posted Date
- 2019-12-18
- Lead Sponsor
- OPKO IP Holdings II, Inc.
- Target Recruit Count
- 213
- Registration Number
- NCT01651000
- Locations
- 🇺🇸
OPKO Renal, Bannockburn, Illinois, United States
Pharmacokinetics and Safety Pilot Study of Single-Dose Oral and Intravenous CTAP101 in Stage 3 and 4 Chronic Kidney Disease Subjects
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-04-24
- Last Posted Date
- 2014-09-30
- Lead Sponsor
- OPKO IP Holdings II, Inc.
- Target Recruit Count
- 28
- Registration Number
- NCT00888069
- Locations
- 🇺🇸
Western New England Renal & Transplant Associates, Springfield, Massachusetts, United States
🇺🇸Pivotal Research Centers, Peoria, Arizona, United States
🇺🇸Twin Cities Clinical Research, Brooklyn Center, Minnesota, United States
Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Secondary Hyperparathyroidism (SHPT)
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-11-18
- Last Posted Date
- 2014-09-29
- Lead Sponsor
- OPKO IP Holdings II, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT00792857
- Locations
- 🇺🇸
Pivotal Reseach Centers, Peoria, Arizona, United States
🇺🇸Western New England Renal and Transplant Associates, Springfield, Massachusetts, United States
🇺🇸Northeast Clinical Research, Allentown, Pennsylvania, United States
Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-08-28
- Last Posted Date
- 2014-11-06
- Lead Sponsor
- OPKO IP Holdings II, Inc.
- Target Recruit Count
- 41
- Registration Number
- NCT00742716
- Locations
- 🇨🇦
Humber River Regional Hospital, Weston, Ontario, Canada
🇺🇸U.S. Renal Care, Fort Worth, Texas, United States
🇺🇸Western New England Renal & Transplant Associates (WNERTA), Springfield, Massachusetts, United States
© Copyright 2024. All Rights Reserved by MedPath